Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Trop Biomed ; 27(3): 595-610, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21399602

RESUMO

The spread of multi-drug resistant tuberculosis necessitates the discovery of new classes of antibacterials and compounds that inhibit macromolecules involved in these resistant mechanisms. Thirty ethanol extracts from nineteen selected plants from Zimbabwe were screened against Mycobacterium aurum and Corynebacterium glutamicum using the agar disk diffusion method. These two organisms were used as models for Mycobacterium tuberculosis. The amount of ciprofloxacin accumulated and effluxed by the test organism was used to determine whether the plant extracts could also act as drug efflux pump inhibitors. Vernonia adoensis and Mangifera indica extracts at 500 mg/disk had the highest growth inhibitory activity against M. aurum and C. glutamicum respectively. The extract from Parinari curatellifolia had an MIC of 8 µg/ disk and an MBC of 63 µg/disk; an MIC of 125 µg/disk and an MBC of >500 µg/disk against M. aurum and C. glutamicum respectively. All the plant extracts were bacteriostatic and showed antagonistic effects when combined with rifampicin. The extract from P. curatellifolia made M. aurum and C. glutamicum accumulate the highest amount of ciprofloxacin. The accumulation of ciprofloxacin caused by P. curatellifolia extract was greater than that caused by the drug efflux inhibitor reserpine. This plant may serve as a source of lead compounds in the search of new antimycobacterials with new mechanisms of action.


Assuntos
Antibacterianos/farmacologia , Corynebacterium glutamicum/efeitos dos fármacos , Mycobacterium/efeitos dos fármacos , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Antibacterianos/isolamento & purificação , Ciprofloxacina/metabolismo , Corynebacterium glutamicum/crescimento & desenvolvimento , Corynebacterium glutamicum/metabolismo , Humanos , Proteínas de Membrana Transportadoras/metabolismo , Testes de Sensibilidade Microbiana/métodos , Viabilidade Microbiana/efeitos dos fármacos , Mycobacterium/crescimento & desenvolvimento , Mycobacterium/metabolismo , Extratos Vegetais/isolamento & purificação , Zimbábue
2.
J Insect Physiol ; 49(3): 223-9, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12769997

RESUMO

The presence of glutathione transferases and esterase activity was investigated in Rhopalosiphum padi and the effects of the cereal hydroxamic acid, 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) on these detoxification enzymes was studied. Activity of glutathione S-transferases and general esterases was determined for adult aphids feeding on a natural diet lacking DIMBOA and on an artificial DIMBOA-containing diet for 48 hours. In vivo, DIMBOA in the diet inhibited the activities of esterases by 50-75% at all concentrations tested (0.5-4 mM). The activity of glutathione transferase was inhibited to a lesser extent (30%) at the higher concentrations of DIMBOA. In vitro, DIMBOA generally inhibited the activity of esterases with an IC(50) of 33 micro M, and had a slight inhibitory effect on glutathione S-transferases. These effects of DIMBOA could make the aphids vulnerable to electrophilic agents and insecticides which may be metabolized via esterases and GSTs. In cereals, therefore, DIMBOA may act by interfering with esterase- or GST-mediated detoxification of xenobiotics by aphids.


Assuntos
Afídeos/enzimologia , Esterases/metabolismo , Glutationa Transferase/metabolismo , Inseticidas/farmacocinética , Oxazinas/farmacologia , Animais , Benzoxazinas , Dieta , Relação Dose-Resposta a Droga , Grão Comestível , Esterases/efeitos dos fármacos , Glutationa Transferase/antagonistas & inibidores , Glutationa Transferase/efeitos dos fármacos , Inativação Metabólica , Cinética
3.
Free Radic Res ; 35(4): 427-34, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11697139

RESUMO

Artemisinin is a sesquiterpene lactone containing an endoperoxide bridge. It is a promising new antimalarial and is particularly useful against the drug resistant strains of Plasmodium falciparum. It has unique antimalarial properties since it acts through the generation of free radicals that alkylate parasite proteins. Since the antimalarial action of the drug is antagonised by glutathione and ascorbate and has unusual pharmacokinetic properties in humans, we have investigated if the drug is broken down by a typical reductive reaction in the presence of glutathione transferases. Cytosolic glutathione transferases (GSTs) detoxify electrophilic xenobiotics by catalysing the formation of glutathione (GSH) conjugates and exhibit glutathione peroxidase activity towards hydroperoxides. Artemisinin was incubated with glutathione, NADPH and glutathione reductase and GSTs in a coupled assay system analogous to the standard assay scheme with cumene hydroperoxide as a substrate of GSTs. Artemisinin was shown to stimulate NADPH oxidation in cytosols from rat liver, kidney, intestines and in affinity purified preparations of GSTs from rat liver. Using human recombinant GSTs hetelorogously expressed in Escherichia coli, artemisinin was similarly shown to stimulate NADPH oxidation with the highest activity observed with GST M1-1. Using recombinant GSTs the activity of GSTs with artemisinin was at least two fold higher than the reaction with CDNB. Considering these results, it is possible that GSTs may contribute to the metabolism of artemisinin in the presence of NADPH and GSSG-reductase. We propose a model, based on the known reactions of GSTs and sesquiterpenes, in which (1) artemisinin reacts with GSH resulting in oxidised glutathione; (2) the oxidised glutathione is then converted to reduced glutathione via glutathione reductase; and (3) the latter reaction may then result in the depletion of NADPH via GSSG-reductase. The ability of artemisinin to react with GSH in the presence of GST may be responsible for the NADPH utilisation observed in vitro and suggests that cytosolic GSTs are likely to be contributing to metabolism of artemisinin and related drugs in vivo.


Assuntos
Antimaláricos/metabolismo , Artemisininas , Glutationa Transferase/metabolismo , Sesquiterpenos/metabolismo , Animais , Derivados de Benzeno/metabolismo , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Glutationa S-Transferase pi , Humanos , Técnicas In Vitro , Isoenzimas/metabolismo , Rim/enzimologia , Fígado/enzimologia , Masculino , NADP/metabolismo , Oxirredução , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/metabolismo
4.
Clin Chim Acta ; 265(2): 145-55, 1997 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-9385457

RESUMO

The frequency of the null allele phenotype of glutathione S-transferase (GST) M1 was investigated in 114 Zimbabweans and results for a subset of 63 subjects were compared with genotyping by PCR. In addition, the effect of the antimalarial chloroquine on blood levels of GSTM1 and GSTA in 19 subjects was studied. Quantification of GSTs was by enzyme linked immunosorbent assays (ELISA). Thirty percent of the subjects were of the GSTM1 null phenotype. Comparison of results of phenotyping by ELISA and genotyping by PCR showed that 16% of samples were in discordance; unknown mutations in the GSTM1 gene in the Zimbabwean population may explain this observation. Chloroquine decreased levels of blood GSTM1 and GSTA by 50% or more. In populations treated with chloroquine, these decreases in GST activities might lead to compromised ability to detoxify xenobiotics, could confound GSTM1 phenotyping and might invalidate use of GSTA as an indicator of liver damage.


Assuntos
Antimaláricos/farmacologia , Cloroquina/farmacologia , Glutationa Transferase/sangue , Glutationa Transferase/efeitos dos fármacos , Isoenzimas/sangue , Isoenzimas/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Glutationa Transferase/genética , Humanos , Isoenzimas/genética , Masculino , Fenótipo , Polimorfismo Genético
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...